1. Skittrall JP, Fortune MD, Jalal H, Zhang H, Enoch DA, Brown NM, et al. Diagnostic tool or screening programme? Asymptomatic testing for SARS-CoV-2 needs clear goals and protocols. The Lancet Regional Health - Europe. 2021;1:100002.
2. Centers for Disease Control and Prevention (CDC). Interim Guidance for SARS-CoV-2 Testing in Non-Healthcare Workplaces. Available from: https://www.cdc.gov/coronavirus/2019-ncov/community/organizations/testing-non-healthcare-workplaces.html. 2021.
3. UK Government. Get coronavirus tests for your employees. Available at: https://www.gov.uk/get-workplace-coronavirus-tests. 2021.
4. Raffle AE, Pollock AM, Harding-Edgar L. Covid-19 mass testing programmes. BMJ. 2020:m3262.
5. Rough E. Coronavirus: testing for covid-19. House of Commons briefing paper. 5 Aug 2020. Available at: https://commonslibrary.parliament.uk/research-briefings/cbp-8897/. 2020.
6. Buitrago-Garcia D, Egli-Gany D, Counotte MJ, Hossmann S, Imeri H, Ipekci MA, et al. Asymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. medRxiv. 2020:2020.04.25.20079103.
7. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 16 March 2020. 2020.
8. Raffle AE. Screening the healthy population for covid-19 is of unknown value, but is being introduced nationwide. The BMJ Opinion. 2020;371.
9. Mahase E. Covid-19: People are not being warned about pitfalls of mass testing. BMJ. 2021:n238.
10. Cox C, Dixon-Woods M. Need for ethical framework to guide mass testing for asymptomatic covid-19. BMJ. 2020:m4567.
11. Kalokairinou L, Zettler PJ, Nagappan A, Kyweluk MA, Wexler A. The promise of direct-to-consumer COVID-19 testing: ethical and regulatory issues. Journal of Law and the Biosciences. 2020;7(1).
12. SAGE Multidisciplinary Task and Finish Group on Mass Testing (TFMS). Consensus Statement for the Scientific Advisory Group for Emergencies (SAGE). 2020.
13. Studdert DM, Hall MA. Disease Control, Civil Liberties, and Mass Testing — Calibrating Restrictions during the Covid-19 Pandemic. New England Journal of Medicine. 2020;383(2):102-4.
14. Wise J. Covid-19: Government uses lateral flow tests to keep children in schools against regulator’s advice. BMJ. 2021:n148.
15. Pollock AM. Testing, testing…for SARS-CoV-2 in asymptomatic people. Available at: https://blogs.bmj.com/bmj/2021/02/09/allyson-pollock-testing-testing-for-sars-cov-2-in-asymptomatic-people/. The BMJ Opinion. 2021.
16. Iacobucci G. Covid-19: Mass testing at UK universities is haphazard and unscientific, finds BMJ investigation. BMJ. 2021:n848.
17. Johnson-León M, Caplan AL, Kenny L, Buchan I, Fesi L, Olhava P, et al. Executive summary: It's wrong not to test: The case for universal, frequent rapid COVID-19 testing. EClinicalMedicine. 2021;33:100759.
18. Cox C, Ansari A, McLaughlin M, Van Der Scheer J, Liddell K, Burt J, et al. Developing an ethical framework for asymptomatic COVID-19 testing programmes in higher education institutions. Wellcome Open Research. 2021;6:101.
19. Iacobucci G. Covid-19: Government rolls out twice weekly rapid testing to all in England. BMJ. 2021:n902.
20. Advisory Conciliation and Arbitration Service (ACAS). Working safely during coronavirus. Available at: https://www.acas.org.uk/working-safely-coronavirus/testing-staff-for-coronavirus. 2021.
21. Information Commissioner's Office (ICO). Data protection and coronavirus – advice for organisations. Available at: https://ico.org.uk/global/data-protection-and-coronavirus-information-hub/coronavirus-recovery-data-protection-advice-for-organisations/. 2021.
22. UK Government. Coronavirus (COVID-19): testing guidance for employers: guidance. Annex B: employer's legal obligations. Available at: https://www.gov.uk/government/publications/coronavirus-covid-19-testing-guidance-for-employers/annex-a-employers-legal-obligations. 2021.
23. Kuhn E, Müller S, Heidbrink L, Buyx A. The Ethics of Workplace Health Promotion. Public Health Ethics. 2020;13(3):234-46.
24. Robroek SJW, van de Vathorst S, Hilhorst MT, Burdorf A. Moral issues in workplace health promotion. International archives of occupational and environmental health. 2012;85(3):327-31.
25. Sorrell J. Ethics: Employer-sponsored wellness programs for nurses: The ethics of carrots and sticks. OJIN: The Online Journal of Issues in Nursing. 2015;20(1).
26. Van Berkel J, Meershoek A, Janssens RM, Boot CR, Proper KI, Van Der Beek AJ. Ethical considerations of worksite health promotion: an exploration of stakeholders’ views. BMC Public Health. 2014;14(1):458.
27. Cashman CM, Ruotsalainen JH, Greiner BA, Beirne PV, Verbeek JH. Alcohol and drug screening of occupational drivers for preventing injury. Cochrane Database of Systematic Reviews. 2009(2).
28. Gibson TM, Loza-Herrero MA, Yepes JF, Kim-Berman H, Dilbone DA, Perez H. Mandatory Drug Testing of Dental Students: To Test or Not to Test. Journal of Dental Education. 2019;83(8):924.
29. Christie T. A discussion of the ethical implications of random drug testing in the workplace. Healthcare Management Forum. 2015;28(4):172-4.
30. Schmid P, Rauber D, Betsch C, Lidolt G, Denker M-L. Barriers of Influenza Vaccination Intention and Behavior - A Systematic Review of Influenza Vaccine Hesitancy, 2005 - 2016. PloS one. 2017;12(1):e0170550.
31. Ishizaki A, Bouscaillou J, Luhmann N, Liu S, Chua R, Walsh N, et al. Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries. BMC Infectious Diseases. 2017;17(S1).
32. World Health Organization. Guidelines on hepatitis B and C testing. Available at: https://www.who.int/hepatitis/publications/guidelines-hepatitis-c-b-testing/en/. 2017.
33. Fritz Z, Huxtable R, Ives J, Paton A, Slowther AM, Wilkinson D. Ethical road map through the covid-19 pandemic. 2020;369:m2033.
34. Dixon-Woods M. Testing times: An ethical framework for swab testing of NHS workers for covid-19. Available at: https://blogs.bmj.com/bmj/2020/07/21/testing-times-an-ethical-framework-for-swab-testing-of-nhs-workers-for-covid-19/. The BMJ Opinion. 2020.
35. SAGE Multidisciplinary Task and Finish Group on Mass Testing. Behavioural Considerations. 2020.
36. FDA. Pooled Sample Testing and Screening Testing for COVID-19. Available at: https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/pooled-sample-testing-and-screening-testing-covid-19. 2020.
37. UK government. Coronavirus (COVID-19): testing guidance for employers. Available at: https://www.gov.uk/government/publications/coronavirus-covid-19-testing-guidance-for-employers. 2021.
38. Personnel Today. Legal risks of Covid-19 testing in the workplace. Available at: https://www.personneltoday.com/hr/legal-risks-of-covid-19-testing-in-the-workplace/. 2020.
39. UK government. NHS Test and Trace in the workplace: Guidance. Available at: https://www.gov.uk/guidance/nhs-test-and-trace-workplace-guidance#guidance-for-employers. 2021.
40. European Commission. In vitro diagnostic medical devices. Annex 1 of the EU Directive 98/79/EC. 2020.
41. FDA. Overview of IVD Regulation. 2019.
42. UK Government. Guidance on the regulation of In Vitro Diagnostic medical devices in Great Britain. Available at: https://www.gov.uk/government/publications/in-vitro-diagnostic-medical-devices-guidance-on-legislation. 2021.
43. Health and Safety Executive (HSE). Health and safety for disabled people and their employers: The law. Available at: https://www.hse.gov.uk/disability/law.htm. 2015.
44. UK Equality and Human Rights Commission. Coronavirus (COVID-19) and the equality duty. Available at: https://www.equalityhumanrights.com/en/advice-and-guidance/coronavirus-covid-19-and-equality-duty-0. 2021.
45. Rutter H, Wolpert M, Greenhalgh T. Managing uncertainty in the covid-19 era. BMJ. 2020:m3349.
46. Childress JF, Faden RR, Gaare RD, Gostin LO, Kahn J, Bonnie RJ, et al. Public Health Ethics: Mapping the Terrain. The Journal of Law, Medicine & Ethics. 2002;30(2):170-8.
47. Marckmann G, Schmidt H, Sofaer N, Strech D. Putting public health ethics into practice: a systematic framework. Frontiers in Public Health. 2015;3.
48. Thompson AK, Faith K, Gibson JL, Upshur RE. Pandemic influenza preparedness: an ethical framework to guide decision-making. BMC Med Ethics. 2006;7:E12.
49. Dunn M, Sheehan M, Hope T, Parker M. Toward methodological innovation in empirical ethics research. Cambridge Q Healthcare Ethics. 2012;21:466.
50. THIS Institute. Testing Times: An ethical framework and practical recommendations for COVID-19 testing for NHS workers. 2020.
51. Kass NE. An ethics framework for public health. American journal of public health. 2001;91(11):1776-82.
52. Lee LM. Public Health Ethics Theory: Review and Path to Convergence. Journal of Law, Medicine & Ethics. 2012;40(1):85-98.
53. Thompson AK, Faith K, Gibson JL, Upshur RE. Pandemic influenza preparedness: an ethical framework to guide decision-making. BMC Medical Ethics. 2006;7(1):12.
54. World Health Organization. Ethical considerations in developing a public health response to pandemic influenza. Available at: https://www.who.int/csr/resources/publications/WHO_CDS_EPR_GIP_2007_2c.pdf. 2007.
55. World Health Organization. Guidance For Managing Ethical Issues in Infectious Disease Outbreaks. Available at: https://www.who.int/ethics/publications/infectious-disease-outbreaks/en/. 2016.
56. Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful Sampling for Qualitative Data Collection and Analysis in Mixed Method Implementation Research. Administration and Policy in Mental Health and Mental Health Services Research. 2015;42(5):533-44.
57. Fricker RD. Sampling methods for web and e-mail surveys. The SAGE handbook of online research methods. 2008:195-216.
58. Creswell JW, Plano Clark VL, Gutmann ML, Hanson WE. Advanced mixed methods research designs. In: Tashakkori A, Teddlie C, editors. Handbook of mixed methods in social and behavioral research. California2013.
59. Fetters MD, Curry LA, Creswell JW. Achieving Integration in Mixed Methods Designs-Principles and Practices. Health Services Research. 2013;48(6pt2):2134-56.
60. Moseholm E, Fetters MD. Conceptual models to guide integration during analysis in convergent mixed methods studies. Methodological Innovations. 2017;10(2):205979911770311.
61. Heiberger RM, Robbins NB. Design of diverging stacked bar charts for Likert scales and other applications. Journal of Statistical Software. 2014;57(5):1-32.
62. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL: https://www.R-project.org/. 2017.
63. Galel N, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13:117.
64. Malterud K, Siersma VD, Guassora AD. Sample Size in Qualitative Interview Studies. Qualitative Health Research. 2016;26(13):1753-60.
65. Bensimon CM, Upshur RE. Evidence and effectiveness in decisionmaking for quarantine. American journal of public health. 2007;97(Supplement_1):S44-S8.
66. Raffle AE, Gray JM. Screening: evidence and practice: Oxford University Press, USA; 2019.
67. Araz OM, Ramirez-Nafarrate A, Jehn M, Wilson FA. The importance of widespread testing for COVID-19 pandemic: systems thinking for drive-through testing sites. Health Systems. 2020;9(2):119-23.
68. Kucharski AJ, Klepac P, Conlan AJ, Kissler SM, Tang ML, Fry H, et al. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study. The Lancet Infectious Diseases. 2020;20(10):1151-60.
69. MacIntyre CR. Case isolation, contact tracing, and physical distancing are pillars of COVID-19 pandemic control, not optional choices. The Lancet Infectious Diseases. 2020;20(10):1105-6.
70. HSE Workplace Health Expert Committee (WHEC). SARS-CoV-2: testing and the workplace: Rapid review to 16th February 2021. Available at: https://www.hse.gov.uk/coronavirus/assets/docs/testing-and-the-workplace.pdf. 2021.
71. Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Annals of internal medicine. 2020;173(5):362-7.
72. Schuetz AN, Hemarajata P, Mehta N, Campbell S, Mitchell S, Palavecino E, et al. When Should Asymptomatic Persons Be Tested for COVID-19? Journal of Clinical Microbiology. 2021;59(1):1-7.
73. Bosetti P, Kiem CT, Yazdanpanah Y, Fontanet A, Lina B, Colizza V, et al. Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France. Eurosurveillance. 2021;26(1):2001978.
74. Sturdy S, Miller F, Hogarth S, Armstrong N, Chakraborty P, Cressman C, et al. Half a Century of Wilson & Jungner: Reflections on the Governance of Population Screening. Wellcome Open Research. 2020;5:158.
75. Wilson JMG, Jungner G, Organization WH. Principles and practice of screening for disease. 1968.
76. Waller J, Bartoszek M, Marlow L, Wardle J. Barriers to cervical cancer screening attendance in England: a population-based survey. Journal of medical screening. 2009;16(4):199-204.
77. Figueroa C, Johnson C, Verster A, Baggaley R. Attitudes and acceptability on HIV self-testing among key populations: a literature review. AIDS and Behavior. 2015;19(11):1949-65.
78. Krause J, Subklew-Sehume F, Kenyon C, Colebunders R. Acceptability of HIV self-testing: a systematic literature review. BMC public health. 2013;13(1):735.
79. Mahase E. Covid-19: Mass testing is inaccurate and gives false sense of security, minister admits. BMJ. 2020;371:m4916.
80. Wise J. Covid-19: Lateral flow tests miss over half of cases, Liverpool pilot data show. BMJ. 2020;371:m4848.
81. Gray N, Calleja D, Wimbush A, Miralles-Dolz E, Gray A, De Angelis M, et al. Is “no test is better than a bad test”? Impact of diagnostic uncertainty in mass testing on the spread of COVID-19. PloS one. 2020;15(10):e0240775.
82. Santiago I. Trends and innovations in biosensors for COVID‐19 mass testing. ChemBioChem. 2020;21(20):2880.
83. Sunjaya AF, Sunjaya AP. Pooled testing for expanding COVID-19 mass surveillance. Disaster Medicine and Public Health Preparedness. 2020;14(3):e42-e3.
84. Crozier A, Rajan S, Buchan I, McKee M. Put to the test: use of rapid testing technologies for covid-19. bmj. 2021;372.
85. Vandenberg O, Martiny D, Rochas O, van Belkum A, Kozlakidis Z. Considerations for diagnostic COVID-19 tests. Nature Reviews Microbiology. 2020:1-13.
86. Martela F, Hankonen N, Ryan RM, Vansteenkiste M. Motivating voluntary compliance to behavioural restrictions: Self-determination theory–based checklist of principles for COVID-19 and other emergency communications. European Review of Social Psychology. 2021:1-43.
87. Harris J, Holm S. Is there a moral obligation not to infect others? BMJ. 1995;311(7014):1215-7.
88. Barbera J, Macintyre A, Gostin L, Inglesby T, O'Toole T, DeAtley C, et al. Large-scale quarantine following biological terrorism in the United States: scientific examination, logistic and legal limits, and possible consequences. Jama. 2001;286(21):2711-7.
89. Giubilini A, Douglas T, Maslen H, Savulescu J. Quarantine, isolation and the duty of easy rescue in public health. Developing world bioethics. 2018;18(2):182-9.
90. Upshur R. The ethics of quarantine. AMA Journal of Ethics. 2003;5(11):393-5.
91. Upshur RE. Principles for the justification of public health intervention. Canadian Journal of Public Health. 2002;93(2):101-3.
92. Patel J, Fernandes G, Sridhar D. How can we improve self-isolation and quarantine for covid-19? BMJ. 2021;372:n625.
93. Cevik M, Baral SD, Crozier A, Cassell JA. Support for self-isolation is critical in covid-19 response. BMJ. 2021;372:n224.
94. Stokel-Walker C. Covid-19: Why test and trace will fail without support for self-isolation. bmj. 2021;372.
95. Smith LE, Potts HW, Amlot R, Fear NT, Michie S, Rubin J. Adherence to the test, trace and isolate system: results from a time series of 21 nationally representative surveys in the UK (the COVID-19 Rapid Survey of Adherence to Interventions and Responses [CORSAIR] study). BMJ. 2021;In press.
96. Owens J, Cribb A. Beyond choice and individualism: understanding autonomy for public health ethics. Public Health Ethics. 2013;6(3):262-71.
97. Zimmerman FJ. Public health autonomy: a critical reappraisal. Hastings Center Report. 2017;47(6):38-45.
98. Smith CB, Battin MP, Jacobson JA, Francis LP, Botkin JR, Asplund EP, et al. Are there Characteristics of Infectious Diseases that Raise Special Ethical Issues? 1. Developing World Bioethics. 2004;4(1):1-16.
99. Nuffield Council on Bioethics. Public health: ethical issues. Available at: https://www.nuffieldbioethics.org/publications/public-health. 2007.
100. Van Buren HJ, Greenwood M. Enhancing Employee Voice: Are Voluntary Employer–Employee Partnerships Enough? Journal of Business Ethics. 2008;81(1):209-21.
101. Lee L. Public Health Ethics Theory: Review and Path to Convergence. Journal of Law, Medicine and Ethics. 2012;40(1):85-98.
102. Raffle AE, Pollock AM, Harding-Edgar L. Covid-19 mass testing programmes. British Medical Journal Publishing Group; 2020.
103. Screening STaFGoM. Multidisciplinary Task and Finish Group on Mass Testing: Consensus Statement for SAGE. 2020.
104. Manno M, Sito F, Licciardi L. Ethics in biomonitoring for occupational health. Toxicology Letters. 2014;231(2):111-21.
105. Blendon RJ, DesRoches CM, Cetron MS, Benson JM, Meinhardt T, Pollard W. Attitudes toward the use of quarantine in a public health emergency in four countries. Health Aff (Millwood). 2006;25(2):w15-25.
106. Van Hooste WLC, Bekaert M. To Be or Not to Be Vaccinated? The Ethical Aspects of Influenza Vaccination among Healthcare Workers. International journal of environmental research and public health. 2019;16(20):3981.
107. Have Mt, van der Heide A, Mackenbach JP, de Beaufort ID. An ethical framework for the prevention of overweight and obesity: a tool for thinking through a programme’s ethical aspects. European Journal of Public Health. 2012;23(2):299-305.
108. Hunt MK, Lederman R, Stoddard AM, LaMontagne AD, McLellan D, Combe C, et al. Process Evaluation of an Integrated Health Promotion/Occupational Health Model in WellWorks-2. Health Education & Behavior. 2005;32(1):10-26.
109. Carolan S, Harris PR, Cavanagh K. Improving Employee Well-Being and Effectiveness: Systematic Review and Meta-Analysis of Web-Based Psychological Interventions Delivered in the Workplace. Journal of Medical Internet Research. 2017;19(7):e271.
110. Pieper C, Schröer S, Eilerts A-L. Evidence of Workplace Interventions—A Systematic Review of Systematic Reviews. International Journal of Environmental Research and Public Health. 2019;16(19):3553.
111. Proper KI, Van Oostrom SH. The effectiveness of workplace health promotion interventions on physical and mental health outcomes – a systematic review of reviews. Scandinavian Journal of Work, Environment & Health. 2019;45(6):546-59.
112. Quirk H, Crank H, Carter A, Leahy H, Copeland RJ. Barriers and facilitators to implementing workplace health and wellbeing services in the NHS from the perspective of senior leaders and wellbeing practitioners: a qualitative study. BMC public health. 2018;18(1):1362-.
113. Rongen A, Robroek SJW, van Ginkel W, Lindeboom D, Pet M, Burdorf A. How needs and preferences of employees influence participation in health promotion programs: a six-month follow-up study. BMC Public Health. 2014;14(1):1277.